ClinicalTrials.gg
RecruitingNCT06193915Updated Mar 19, 2024

Ultrasound Guided Hematoma Block in Distal Radius Fractures

An interventional study of Ultrasound guided hematoma block. and Blind hematoma block in Distal Radius Fractures, Fracture Dislocation and Dislocated Wrist, sponsored by Medical Centre Leeuwarden. Recruiting at 1 site in Netherlands. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2024-03-19.

Sponsored by Medical Centre Leeuwarden · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 11 months ago, but the record still lists the study as recruiting.
  • Started Jan 2024; still recruiting 2 years 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
16 Years and older
Sex
All
01

Study summary

This study will investigate the effectiveness of analgesia of ultrasound hematoma block compared to 'blind' hematoma block in patients with dislocated distal radius fracture.

Read the detailed description

Distal radius fractures represent one of the most common injuries in the Emergency Department (ED). Proper treatment especially for dislocated fractures can minimize the chance of residual injury. For closed reduction anesthesia is essential for safety, satisfaction and result. Different methods of regional anesthesia can be used but hematoma block (HB) is the technique most often used in EDs in the Netherlands and recommended by Dutch guidelines. In practice however a HB, does not always lead to adequate anesthesia, this might be because of poor infiltration into the fracture site. Ultrasound could additionally provide real-time guidance of injection into the fracture site, maximizing the analgesic effect of HB. In this study the effectiveness of analgesia of ultrasound HB will be compared to 'blind' HB in patients with a dislocated distal radius fracture.

Patients with a confirmed dislocated fracture of the distal radius requiring closed reduction will be randomized to either ultrasound guided hematoma block or normal 'blind' hematoma block. NRS-scores will be given before, during and after hematoma block and during and after reduction of the fracture. These scores will be the primary endpoint of this study.

02

Conditions studied

  • Distal Radius Fractures
  • Fracture Dislocation
  • Dislocated Wrist
  • Dislocated Radius

Browse trials for

Keywords

  • Distal radius fracture
  • Ultrasound
  • Hematoma block
03

In context

Wrist Fractures

330 studies on the registry are indexed under Wrist Fractures; 73 are open to participants now.

This study's planned enrollment of 40 is below the median of 62 across 265 interventional studies indexed under Wrist Fractures.

Browse Wrist Fractures studies →

Lead sponsor

Medical Centre Leeuwarden is the lead sponsor of 41 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥ 16 years
  • Confirmed fracture of the distal radius requiring closed reduction, defined as any off the following items(7):

    • >10 degrees of dorsal angulation;
    • >20 degrees of volar angulation;
    • >2 mm step-off intra-articular;
    • >3 mm radial shortening;
    • >15 degrees radial inclination;
    • Translation and non-intact radio-carpal alignment in the lateral view
    • Significant translation in the posterior-anterior(PA)-view.

Exclusion criteria

Exclusion Criteria:

  • No can be given (cognitive impairment, severe dementia, no knowledge of Dutch language e.a.)
  • Neurovascular compromise or open fractures requiring (immediate) surgery or reduction.
  • First reduction already performed
  • Multi-trauma patients requiring other urgent procedures/tests or with respiratory or hemodynamical compromise
  • Pre-existent osteosynthesis material in situ in the affected arm
  • Skin injury (with exception of minor abrasions), local infection or recent burns hindering or contra-indicating the use of ultrasound and ultrasound gel
  • Allergy for local anesthetics
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Ultrasound guided hematoma block

    Patients in this group will receive ultrasound guided hematoma block before reduction of their dislocated distal radius fracture.

    Device: Ultrasound guided hematoma block.

  • Active comparator
    Blind hematoma block

    Patients in this group will receive standard treatment; hematoma block with palpation of the fracture site (blind hematoma block)

    Procedure: Blind hematoma block

Interventions

  • DeviceUltrasound guided hematoma block.

    Patients with a dislocated fracture of the distal radius will receive ultrasound guided hematoma block with 10mL lidocaine 2% to get real-time guidance of the given anesthesia into the fracture site before closed reduction of a distal radius fracture.

  • ProcedureBlind hematoma block

    Patients with a distal radius fracture will receive standard treatment; hematoma block with 10mL 2% lidocaine performed with palpation of the fracture site (blind hematoma block) before closed reduction of dislocated distal radius fractures.

06

What researchers measure

Primary outcomes

  1. Effectiveness of analgesia during closed reduction of a distal radius fracture

    Pain reduction will be measured on a Numeric Rating Scale( NRS-scale; 0-10) at different moments

    Time frame: NRS before, during and after (10-15 min) injection of hematoma block, NRS-score during closed reduction and after closed reduction (5 min)

Secondary outcomes

  1. Number of participants in which hematoma was aspirated during hematoma block

    Measure of correct position of hematoma block if there is aspiration of blood (yes/no)

    Time frame: During hematoma block

  2. Procedural time of the Hematoma block

    Time needed to perform HB (blind or ultrasound-guided; from moment of localization of the fracture until the moment the needle is out of the patient)

    Time frame: Time from insertion of the needle until needle is withdrawn out of the patient (up to maximum of 30 min.)

  3. Procedural time of the reduction

    Time needed to perform reduction of the fracture

    Time frame: From moment physician is ready to start the reduction until cast is applied (up to maximum of 30 min.)

  4. Satisfaction of the HB provided by physician performing the HB procedure

    measured on a 5-points Likert-scale (Very satisfied, Somewhat satisfied, Neither satisfied nor dissatisfied, Somewhat dissatisfied or Very dissatisfied)

    Time frame: 10-15 minutes after hematoma block

  5. Satisfaction of reduction provided by physician performing reduction measured

    measured on a 5-points Likert-scale (Very satisfied, Somewhat satisfied, Neither satisfied nor dissatisfied, Somewhat dissatisfied or Very dissatisfied)

    Time frame: 10-15 minutes after closed reduction

  6. Satisfaction of the patient for procedure and reduction

    measured on a 5-points Likert-scale (Very satisfied, Somewhat satisfied, Neither satisfied nor dissatisfied, Somewhat dissatisfied or Very dissatisfied)

    Time frame: 10-15 minutes after closed reduction

  7. Satisfaction of the nurse for procedure and reduction

    measured on a 5-points Likert-scale (Very satisfied, Somewhat satisfied, Neither satisfied nor dissatisfied, Somewhat dissatisfied or Very dissatisfied)

    Time frame: 10-15 minutes after closed reduction

  8. Number of reductions

    Defined as attempt(s) to align fracture and application of cast

    Time frame: (up to) 10-15 minutes after last closed reduction attempt

  9. Years of experience of treating physician in performing HB.

    Years of experience of treating physician in performing HB.

    Time frame: (up to) 10-15 minutes after last closed reduction attempt

  10. Years of experience of treating physician with use of ultrasound.

    Years of experience of treating physician with use of ultrasound.

    Time frame: (up to) 10-15 minutes after last closed reduction attempt

  11. Number of patients in which palpation of an evident step-off near fracture site was felt

    Before performing hematoma block performing physician will palpate if there is a clear step-off near the fracture site (important especially in blind hematoma group)

    Time frame: During performing hematoma block

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2024 (actual). Primary completion is estimated for Dec 2024, 11 months after the start.

Of 125 non-industry interventional studies with no phase under Wrist Fractures, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 50. This study's planned 11 months is below that.

Counting every sponsor, half of 126 studies reached it within 26 months; a quarter within 16 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 21, 2023
First posted
Jan 5, 2024
StartActual
Jan 5, 2024
Primary completionEst.
Dec 2024
CompletionEst.
Dec 2024
Last update
Mar 19, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06193915
Lead sponsor
Medical Centre Leeuwarden
Responsible party
Pieter Veenstra (Principal investigator, Medical Centre Leeuwarden) — Principal investigator
First posted
Jan 5, 2024
Start date
Jan 5, 2024
Primary completion
Dec 2024 (estimated)
Completion
Dec 2024 (estimated)
Last update
Mar 19, 2024

Study contacts

Pieter Veenstra
Contact
pieter.veenstra@mcl.nl
(058) 286 3852
Heleen Lameijer
Contact
heleen.lameijer@mcl.nl
(058) 286 3112
Pieter Veenstra
principal investigator · Medisch Centrum Leeuwarden

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion